DISCOVERY LIFE SCIENCES Executive and Leadership Team

Gregory Herrema, the Chief Executive Officer at DISCOVERY LIFE SCIENCES, directs the overarching corporate strategy and operational execution. Herrema guides the company's market leadership in biospecimen analysis, procurement, distribution, and scientific services, ensuring alignment with the needs of the pharmaceutical, biotechnology, and diagnostics sectors. This leadership role involves fostering an innovative, consultative approach to client engagement, directly addressing complex research obstacles. By championing the integration of cutting-edge genomic research technologies through HudsonAlpha Discovery, Herrema ensures the comprehensive support of discovery, translational, and clinical research initiatives. The Chief Executive Officer's focus remains on driving scientific advancement and delivering faster end results for global partners. Gregory Herrema's strategic vision solidifies DISCOVERY LIFE SCIENCES' position as a premier partner in life sciences research.

Jason Scherer, the Chief Operating Officer at DISCOVERY LIFE SCIENCES, manages the day-to-day operational efficiency and scalability of the company's global services. Scherer oversees the critical functions of biospecimen procurement, analysis, and distribution, ensuring the highest standards of quality and compliance for the pharmaceutical, biotechnology, and diagnostics sectors. This leadership position involves optimizing workflows and resource allocation to support both discovery and translational research initiatives. The Chief Operating Officer plays a vital part in integrating HudsonAlpha Discovery's advanced sequencing and bioinformatics capabilities into the broader operational framework. By focusing on process improvement and operational excellence, Jason Scherer ensures DISCOVERY LIFE SCIENCES consistently delivers on its promise of scientific rigor and accelerated research outcomes. Scherer's operational oversight is fundamental to maintaining the company's market leadership and consultative client engagement model.

McLean Collins, the President, Biospecimens Products & Services at DISCOVERY LIFE SCIENCES, directs the strategic development and delivery of the company's core biospecimen offerings. Collins oversees the end-to-end lifecycle of biospecimen products and services, ensuring scientific integrity and client satisfaction across the pharmaceutical, biotechnology, and diagnostics sectors. This leadership position is critical for maintaining DISCOVERY LIFE SCIENCES' global market leadership in procurement, analysis, and distribution. The President, Biospecimens Products & Services champions the integration of advanced scientific services, including those from HudsonAlpha Discovery, to provide comprehensive support for discovery and translational research. By focusing on operational excellence and innovative solutions, McLean Collins ensures clients receive the highest quality biospecimens and scientific expertise to overcome research challenges. Collins' leadership drives the continuous enhancement of DISCOVERY LIFE SCIENCES' product and service portfolio.

Todd Poley, the Chief Marketing Officer at DISCOVERY LIFE SCIENCES, architects and executes comprehensive marketing strategies to enhance global brand presence and market penetration. Poley oversees all aspects of brand management, market research, and lead generation, ensuring DISCOVERY LIFE SCIENCES remains the recognized global leader in biospecimen analysis and scientific services. This role involves translating complex scientific capabilities into compelling market narratives for the pharmaceutical, biotechnology, and diagnostics industries. The Chief Marketing Officer drives initiatives that highlight the company's innovative, consultative approach and the advanced capabilities of HudsonAlpha Discovery's sequencing and bioinformatics division. By identifying emerging market trends and customer needs, Todd Poley ensures marketing efforts directly support the company's mission to accelerate discovery and translational research. Poley's leadership ensures consistent communication of DISCOVERY LIFE SCIENCES' value proposition across all global markets.

Tamara Bowles, the Chief Human Resources Officer at DISCOVERY LIFE SCIENCES, directs all human capital strategies to support the company's growth and scientific mission. Bowles oversees talent acquisition, employee development, and organizational culture, ensuring DISCOVERY LIFE SCIENCES attracts and retains top scientific and operational talent within the pharmaceutical, biotechnology, and diagnostics industries. This role is crucial for fostering an environment that encourages innovation and a consultative approach among employees. The Chief Human Resources Officer ensures HR policies align with the company's commitment to scientific excellence and the advanced capabilities offered through HudsonAlpha Discovery. By championing employee engagement and professional growth, Tamara Bowles contributes directly to the company's ability to overcome research obstacles and achieve faster end results for clients. Bowles' leadership in human resources strengthens the foundation for DISCOVERY LIFE SCIENCES' continued success.

Stephen Hagan, the Chief Sales Officer at DISCOVERY LIFE SCIENCES, leads the global sales organization, driving revenue growth and expanding market reach. Hagan oversees all sales operations, developing strategies to effectively position DISCOVERY LIFE SCIENCES' comprehensive biospecimen analysis, procurement, and scientific services to the pharmaceutical, biotechnology, and diagnostics industries. This executive role involves cultivating strong client relationships and ensuring a consultative sales approach that addresses specific research needs. The Chief Sales Officer works closely with marketing and operations to communicate the value of HudsonAlpha Discovery's advanced genomic technologies. By focusing on client success and market expansion, Stephen Hagan ensures DISCOVERY LIFE SCIENCES consistently meets and exceeds its commercial objectives. Hagan's sales leadership is integral to the company's mission of accelerating discovery and delivering impactful research outcomes.